Account Manager, Achondroplasia (ACH) - New York City
BioMarin’s Commercial organization supports our global sales and marketing efforts around the world. Our global sales force continues to solidify the company’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific. Come join our team and make a meaningful impact on patients’ lives.
This role will be in the newly created Achondroplasia Field Sales team. Achondroplasia is the most common form of human dwarfism and is characterized by failure of normal conversion of cartilage into bone, which results in disproportionate short stature. This condition is caused by a mutation in the fibroblast growth factor receptor 3 gene (FGFR3), a negative regulator of bone growth. Disproportionate growth between endochondral bone and underlying organs leads to several orthopedic, neurological, respiratory, ear, nose, and throat (ENT) issues and increased mortality.
To counteract the effects caused by the FGFR3 mutation, BioMarin has developed an investigational drug derived from a natural human peptide that is a positive regulator of bone growth. The investigational drug binds to a specific receptor, which initiates intracellular signals that inhibit the overactive FGFR3 pathway. The investigational treatment is being studied in children with achondroplasia under the age of 18 because their bones are still amenable to growth. It is a daily administered subcutaneously at home.
This role is focused on both pre-launch and post-launch activities that will prepare for and launch BioMarin’s first in class therapy for achondroplasia.
This position requires performance driven individuals with strategic problem- solving skills, high business acumen that can work collaboratively with multiple stakeholders. The ideal candidate will have sales experience in pediatric endocrinology clinics and/or comparable experience. Experience launching a first in class, building new therapeutic markets desired. Rare disease experience is preferred.
The Account Manager is responsible for maximizing sales for the achondroplasia product. They must maintain a high level of knowledge on the disease state, product labeling, and work with local advocacy groups. The primary call target is pediatric endocrinology located both in Institutions and office-based setting.
Activities include disease state education to referring HCPs, office readiness for patient starting therapy as well as coordination of multiple departments/stakeholders and BioMarin's field based clinical support team. Skills required include account management, organizational, analytical, and problem-solving. Individuals must be flexible, and adaptable with sensitivity to the potential constraints of a commercial start-up. Must be goal oriented and accountable for their individual performance, while acting in a professional and compliant manner. Cold calling on all targeted specialties is a requirement.
The Account Manager will be responsible for:
- Achieving area sales objectives, market penetration, new patient starts, and revenue targets on a quarterly & annual basis
- Driving demand through clinical selling and education to referring and treating health care providers on achondroplasia and Vosoritide.
- Ability to quickly create a medical home in Pediatric endocrinology to ensure access to care for all appropriate patients
- Implementing an effective business plan to guide strategy, tactics and track progress.
- Developing and maintaining excellent working relationships with all key stakeholders including: Pediatric Endocrinology, genetics (treating) and key referring physicians that could include Pediatrics, Pulmonology, and ENT.
- Ensure relationships and respectful engagement with local and regional Patient Advocacy Groups (LPA chapters) working with internal advocacy team.
- Actively participating in disease awareness efforts and burden/natural history of achondroplasia through professional society meetings (local, state, regional), as assigned.
- Working with other members of the Achondroplasia brand team, and facilitating appropriate collaboration with other functions, such as MSLs, Market Access team, MPS counterparts and other internal stakeholders, as needed.
- Becoming an expert in the clinical data and verbalizing its significance to all stakeholders.
- Proactively providing business insights to internal partners as to the clinical practices of assigned accounts.
- Acting in compliance within a highly regulated industry and consistent with training, policies, guidelines, and their own best judgment while adhering to all company policies assigned to the Account Manager position.
- Ability to work with ambiguity and remain agile as organization needs evolve
- Must be able to work evenings and weekends, as needed, for patient events (both in person and virtual).
- Depending on geography, must have the ability to manage a multi-state territory with diverse customer base.
- Overnight travel is required and will range from 40%- 60% depending on the geography and business needs of the individual territory.
- Bachelor’s degree required.
- At least 5 years of sales experience in biotech/rare disease involving specialty products that are technically challenging and first in class
- Experience with office-based selling in complex model of referral health care providers to prescriber health care providers in newly created market
- Experience working in a field team model with field based clinical support and reimbursement hub model
- Pediatric Endocrinology strongly preferred
- Experience in new product launches and preferably with first in class product
- Experience in a role that works directly with patient advocacy organizations
- Experience and committed too long sales cycle to ensure medical home is created
- Absent a medical or religious reason that prohibits vaccinations, all incoming employees must be vaccinated